ImmunityBio, Inc. (IBRX)
6.02
-0.05
(-0.82%)
USD |
NASDAQ |
Nov 13, 16:00
5.90
-0.12
(-1.99%)
Pre-Market: 09:06
ImmunityBio Total Liabilities (Quarterly) : 1.755B for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.755B |
| June 30, 2026 | 1.674B |
| March 31, 2026 | 1.516B |
| December 31, 2025 | 1.001B |
| September 30, 2025 | 1.042B |
| June 30, 2025 | 971.90M |
| March 31, 2025 | 894.24M |
| December 31, 2024 | 871.06M |
| September 30, 2024 | 1.109B |
| June 30, 2024 | 1.142B |
| March 31, 2024 | 1.092B |
| December 31, 2023 | 1.090B |
| September 30, 2023 | 843.06M |
| June 30, 2023 | 936.41M |
| March 31, 2023 | 875.12M |
| December 31, 2022 | 812.18M |
| September 30, 2022 | 782.02M |
| June 30, 2022 | 739.69M |
| March 31, 2022 | 727.14M |
| December 31, 2021 | 712.82M |
| September 30, 2021 | 404.36M |
| June 30, 2021 | 404.89M |
| March 31, 2021 | 394.76M |
| December 31, 2020 | 34.46M |
| Date | Value |
|---|---|
| September 30, 2020 | 31.91M |
| June 30, 2020 | 26.51M |
| March 31, 2020 | 24.43M |
| December 31, 2019 | 22.44M |
| September 30, 2019 | 24.25M |
| June 30, 2019 | 24.43M |
| March 31, 2019 | 40.45M |
| December 31, 2018 | 35.94M |
| September 30, 2018 | 39.56M |
| June 30, 2018 | 29.80M |
| March 31, 2018 | 29.48M |
| December 31, 2017 | 31.60M |
| September 30, 2017 | 40.03M |
| June 30, 2017 | 48.70M |
| March 31, 2017 | 25.31M |
| December 31, 2016 | 24.08M |
| September 30, 2016 | 21.52M |
| June 30, 2016 | 15.58M |
| March 31, 2016 | 12.93M |
| December 31, 2015 | 10.85M |
| September 30, 2015 | 7.26M |
| June 30, 2015 | 6.039M |
| March 31, 2015 | 3.055M |
| December 31, 2014 | 2.405M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Moderna, Inc. | 6.631B |
| Sarepta Therapeutics, Inc. | 1.637B |
| Oncolytics Biotech, Inc. | 13.34M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Anixa Biosciences, Inc. | 1.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 609.39M |
| Shareholders Equity (Quarterly) | -1.146B |
| Debt to Equity Ratio | -1.131 |
| Current Ratio | 4.270 |
| Net Debt Paydown Yield | -0.90% |